Skip to main content
SpringerLink
Log in

New Thieno-[2,3-d]pyrimidine-Based Functional Antagonist for the Receptor of Thyroid Stimulating Hormone

  • BIOCHEMISTRY, BIOPHYSICS, AND MOLECULAR BIOLOGY
  • Published:
Doklady Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Thyroid stimulating hormone (TSH) receptor antagonists are required for the treatment of TSH-dependent tumors and Graves disease. We developed the compound 5-amino-N-(tert-butyl)-4-(4-iodophenyl)-2-(methylthio)thieno[2,3-d]pyrimidine-6-carboxamide (TP48) and showed that it reduces the TSH-stimulated adenylate cyclase activity in rat thyroid membranes. Pretreatment of rats with compound TP48 (ip, 40 mg/kg) reduced the increase in the levels of total and free thyroxin in blood and the increase in the expression of thyroglobulin and D2 deiodinase genes in the thyroid gland, which are responsible for the synthesis of thyroid hormones, which were caused by intranasal administration of thyroliberin to animals (300 μg/kg). These data indicate that compound TP48 is a functional antagonist of the TSH receptor and can be used to correct the thyroid status in hyperthyroidism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

REFERENCES

  1. Rowe, C.W., Paul, J.W., Gedye, C., et al., Endocr. Relat. Cancer, 2017, vol. 24, pp. R191–R202. https://doi.org/10.1530/ERC-17-0010

    Article  CAS  PubMed  Google Scholar 

  2. Rapoport, B. and McLachlan, S.M., Thyroid, 2007, vol. 17, pp. 911–922.

    Article  CAS  Google Scholar 

  3. Neumann, S. and Gershengorn, M.C., Ann. Endocrinol. (Paris), 2011, vol. 72, pp. 74–76. https://doi.org/10.1016/j.ando.2011.03.002

    Article  CAS  Google Scholar 

  4. Nunez, MiguelR. Sanders, J., et al., Auto Immun. Highlights, 2017, vol. 8, p. 2. https://doi.org/10.1007/s13317-016-0090-1

    Article  CAS  Google Scholar 

  5. Marcinkowski, P., Hoyer, I., Specker, E., et al., Thyroid, 2019, vol. 29, pp. 111–123. https://doi.org/10.1089/thy.2018.0349

    Article  CAS  PubMed  Google Scholar 

  6. Kleinau, G., Worth, C.L., Kreuchwig, A., et al., Front. Endocrinol. (Lausanne), 2017, vol. 8, p. 86. https://doi.org/10.3389/fendo.2017.00086

    Article  Google Scholar 

  7. van Koppen, C.J., Zaman, G.J., Timmers, C.M., et al., Naunyn Schmiedebergs Arch. Pharmacol., 2008, vol. 378, pp. 503–514. https://doi.org/10.1007/s00210-008-0318-3

    Article  CAS  PubMed  Google Scholar 

  8. Nataraja, S.G., Yu, H.N., and Palmer, S.S., Front. Endocrinol. (Lausanne), 2015, vol. 6, p. 142. https://doi.org/10.3389/fendo.2015.00142

    Article  Google Scholar 

  9. Derkach, K.V., Dar’in, D.V., Bakhtyukov, A.A., et al., Biochemistry (Moscow)Suppl. Ser. A: Memb. Cell. Biol., 2016, vol. 10, pp. 294–300. https://doi.org/10.1134/S1990747816030132

    Article  Google Scholar 

  10. Hoyer, I., Haas, A.K., Kreuchwig, A., et al., Biochem. Soc. Trans., 2013, vol. 41, pp. 213–217. https://doi.org/10.1042/BST20120319

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Neumann, S., Kleinau, G., Costanzi, S., et al., Endocrinology, 2008, vol. 149, pp. 5945–5950. https://doi.org/10.1210/en.2008-0836

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Shpakov, A.O., Shpakova, E.A., Tarasenko, I.I., et al., Cell Tissue Biol., 2014, vol. 8, pp. 488–498. https://doi.org/10.1134/S1990519X1406008X

    Article  Google Scholar 

  13. Derkach, K.V., Bogush, I.V., Berstein, L.M., et al., Horm. Metab. Res., 2015, vol. 47, pp. 916–924. https://doi.org/10.1055/s-0035-1547236

    Article  CAS  PubMed  Google Scholar 

  14. Carvalho, D.P. and Dupuy, C., Mol. Cell. Endocrinol., 2017, vol. 458, pp. 6–15. https://doi.org/10.1016/j.mce.2017.01.038

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work was supported by the Russian Science Foundation (no. 19-75-20122). The NMR and mass spectrometric studies were carried out using the resource centers of St. Petersburg State University “Magnetic resonance research methods” and “Methods of analysis of the composition of the substance.”

Author information

Authors and Affiliations

  1. Sechenov Institute of Evolutionary Physiology and Biochemistry of Russian Academy of Sciences, 194223, St.-Petersburg, Russia

    K. V. Derkach, A. A. Bakhtyukov & A. O. Shpakov

  2. Institute of Chemistry, St.-Petersburg State University, 198504, St.-Petersburg, Russia

    V. N. Sorokoumov

Authors
  1. K. V. Derkach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. A. Bakhtyukov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. N. Sorokoumov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. O. Shpakov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. O. Shpakov.

Ethics declarations

COMPLIANCE WITH ETHICAL STANDARDS

Statement on the welfare of animals. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

CONFLICT OF INTEREST

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Derkach, K.V., Bakhtyukov, A.A., Sorokoumov, V.N. et al. New Thieno-[2,3-d]pyrimidine-Based Functional Antagonist for the Receptor of Thyroid Stimulating Hormone. Dokl Biochem Biophys 491, 77–80 (2020). https://doi.org/10.1134/S1607672920020064

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1607672920020064

Keywords:

Search

Navigation